Consolidated Balance Sheets - USD ($)	Mar. 31, 2016	Dec. 31, 2015
Current assets
Cash and cash equivalents	$ 1,662,431	$ 2,173,258
Short term investments	0	1,651,341
Accounts receivable, trade, net of allowance for doubtful accounts of $0 at March 31, 2016 and December 31, 2015	1,190,260	929,289
Inventories	2,018,255	1,834,635
Prepaid expenses and other current assets	435,592	384,414
Total current assets	5,306,538	6,972,937
Property and equipment
Leasehold improvements	1,284,491	1,284,491
Furniture and computer equipment	584,603	557,666
Manufacturing and other equipment	1,025,521	1,025,521
Subtotal	2,894,615	2,867,678
Less: Accumulated depreciation	(1,513,071)	(1,421,279)
Net property and equipment	1,381,544	1,446,399
Internal use software	1,836,220	1,698,735
Intangible asset	2,215,385	2,215,385
Long term deposits	36,166	36,166
Total assets	10,775,853	12,369,622
Current liabilities
Accounts payable	772,870	1,029,373
Accrued expenses and other current liabilities	113,340	146,438
Accrued compensation	463,558	419,766
Deferred rent	130,216	130,216
Total current liabilities	1,479,984	1,725,793
Long term liabilities
Deferred rent, long term	766,044	784,458
Total liabilities	$ 2,246,028	$ 2,510,251
Commitments and contingencies (Note 9)
Shareholders’ equity
Common stock, $0.001 par value; 150,000,000 shares authorized, 12,508,376 and 12,448,391 shares issued and outstanding at March 31, 2016 and December 31, 2015	$ 12,508	$ 12,447
Additional paid-in capital	72,983,853	72,823,398
Accumulated other comprehensive loss	0	(451)
Accumulated deficit	(65,553,751)	(64,326,923)
Total BioLife Solutions, Inc. shareholders' equity	7,442,610	8,508,471
Total non-controlling interest equity	1,087,215	1,350,900
Total shareholders' equity	8,529,825	9,859,371
Total liabilities and shareholders’ equity	$ 10,775,853	$ 12,369,622